Dr. Denis Guttridge Discusses NF-kB Therapy for Duchenne Muscular Dystrophy: December 2011

Guest: Denis Guttridge, PhD, Associate Professor, Molecular Virology, Immunology and Medical Genetics, The Ohio State University

Access an abstract of this month’s featured research articles: Improvement of cardiac contractile function by peptide-based inhibition of NF-κB in the utrophin/dystrophin-deficient murine model of muscular dystrophy. J Transl Med. 2011 May 17;9:68. doi: 10.1186/1479-5876-9-68.

Peptide-based inhibition of NF-κB rescues diaphragm muscle contractile dysfunction in a murine model of Duchenne muscular dystrophy. Mol Med. 2011 May-Jun;17(5-6):508-15. doi: 10.2119/molmed.2010.00263.